UNITED LAB News

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024

Nov 6 08:01 ET

UNITED LAB: THE GROUP'S PRODUCT CEFTAZIDIME FOR INJECTION PASSED THE CONSISTENCY EVALUATION

Oct 25 07:52 ET

UNITED LAB: THE GROUP'S PRODUCT AMOXICILLIN GRANULES PASSED THE CONSISTENCY EVALUATION

Oct 16 10:40 ET

UNITED LAB: UPDATED INFORMATION ON THE GROUP'S PRODUCT INSULIN DEGLUDEC INJECTION

Oct 14 06:40 ET

UNITED LAB: PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL12101 EYE DROPS

Oct 14 06:22 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2024

Oct 2 10:33 ET

UNITED LAB: Notification Letter with Reply Form to Non-registered Holder

Sep 27 09:12 ET

UNITED LAB: Notification Letter with Reply Form to Shareholders

Sep 27 09:08 ET

UNITED LAB: Interim dividend for the six months ended 30 June 2024

Sep 25 08:55 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024

Sep 4 09:44 ET

UNITED LAB: Interim dividend for the six months ended 30 June 2024

Aug 30 00:01 ET

UNITED LAB: PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT UBT251 INJECTION

Aug 12 09:41 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024

Aug 1 23:23 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024

Jul 3 00:29 ET

UNITED LAB: Special dividend for the year ended 31 December 2023

Jul 1 07:51 ET

UNITED LAB: Final dividend for the year ended 31 December 2023

Jul 1 07:48 ET

UNITED LAB: List of Directors and Their Role and Function

Jun 11 08:06 ET

UNITED LAB: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024

Jun 4 00:28 ET

UNITED LAB: Special dividend for the year ended 31 December 2023

May 7 10:46 ET

UNITED LAB: Final dividend for the year ended 31 December 2023

May 7 10:44 ET